Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
Purpose
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Condition
- Patients Transplanted With NiCord/CordIn (Omidubicel)
Eligibility
- Eligible Ages
- Between 2 Years and 65 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.
Exclusion Criteria
- None
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| NiCord®/CordIn™ (omidubicel) transplanted | Anyone who signed the consent for this study received a NiCord®/CordIn™ (omidubicel) infusion as part of a GC clinical interventional study, and completed the interventional study Day 365 status assessment. |
|
More Details
- Status
- Completed
- Sponsor
- Gamida Cell ltd